|
CN108367011A
|
|
Use TLR8 agonist treatment cancers
|
|
AU2016203581A1
|
|
Methods of Enhancing Antibody-Dependent Cellular Cytotoxicity
|
|
WO2012097177A2
|
|
Substituted benzoazepines as toll-like receptor modulators
|
|
MX2013008219A
|
|
Substituted benzoazepines as toll-like receptor modulators.
|
|
CN103458902A
|
|
Therapeutic use of a tlr agonist and combination therapy
|
|
CN103237549A
|
|
Methods for treatment of allergic diseases
|
|
CN103209696A
|
|
Methods of enhancing antibody-dependent cellular cytotoxicity
|
|
CN102781933A
|
|
Substituted benzoazepines as toll-like receptor modulators
|
|
EP2313111A1
|
|
Toll-like receptor agonist formulations and their use
|
